Form 4 for DSGN Design Therapeutics, Inc.
Accepted 2023-10-02 00:00:00 ET · period of report 2023-09-29 · accession 0001209191-23-051175 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-02 | 2023-09-29 | DSGN | LAPPE RODNEY W | Dir | P - Purchase | $2.35 | +21.0K | 133.0K | +19% | +$49.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-29 | P | A | 21,000 | $2.35 | 133,024 | D | — | — | (F1) The price reported in column 4 is a weighted average price. The shares were purchased at a range of prices between $2.33 and $2.38. Upon request by the Securities and Exchange Commission staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided. |